Join our mailing list!

Official PayPal Seal

(Your shopping cart is empty)

  Home > Diane Publishing Books >

Drug Safety: Preliminary Findings Suggest Recent FDA Initiatives Have Potential, but do Not Fully Address Weaknesses in its Foreign Drug Inspection Program: Congressional Testimony
The FDA is responsible for overseeing the safety a

Our Price: $15.00
By Marcia Crosse (au)
Year: 2008
Pages: 19
Binding Paperback

Product Code: 1437904343

The FDA is responsible for overseeing the safety and effectiveness of human drugs that are marketed in the U.S., whether they are manufactured in foreign or domestic estab. FDA inspects foreign estab. to ensure that they meet the same standards required of domestic estab. Ongoing concerns regarding FDAs foreign drug inspection program recently were heightened when FDA learned that contaminated doses of a common blood thinner had been manufactured at a Chinese estab. that the agency had never inspected. FDA has announced initiatives to improve its foreign drug inspection program. This statement presents preliminary findings on how FDAs initiatives address the weaknesses that have been identified. Illustrations.

Share your knowledge of this product with other customers... Be the first to write a review
Diane Publishing Co
PO Box 617
Darby, PA 19023-0617
 About Us
 Become an Affiliate
 Privacy Policy
 Send Us Feedback
Company Info | Advertising | Product Index | Category Index | Help | Terms of Use
Copyright � 2004 Diane Publishing Company. All Rights Reserved.
Built with Volusion